[_SY7] シンポジウム7
小児固形腫瘍に対する遺伝子細胞療法の新展開

[SY7-3] 独自開発の腫瘍溶解性ウイルスSurv.m-CRAのFirst-in-human医師主導治験と実用化の展望
Investigator-initiated first-in-human clinical trial and the prospect to commercialization of the originally developed oncolytic virus Surv.m-CRA

Kenichiro Kosai^1,2,3,8,9, Satoshi Nagano^2,4,8, Nobuhiro Ijichi^1,2,8, Toshitaka Futagawa³, Eriko Sumi⁵, Munekazu Yamaguchi⁶, Masanori Nakajo⁷, Teruto Hashiguchi^2,6,8, Yasuo Takeda^2,3,8, Takashi Yoshiura⁷, Akira Shimizu⁵, Muneo Takatani⁵, Setsuro Komiya^2,4 (1.Department of Gene Therapy and Regenerative Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan, 2.Center for Innovative Therapy, Research and Application, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan, 3.Clinical Research Management Center, Kagoshima University Hospital, Kagoshima, Japan, 4.Department of Orthopaedic Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan, 5.Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan, 6.Department of Laboratory and Vascular Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan, 7.Department of Radiology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan, 8.South Kyushu Center for Innovative Medical Research and Application, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan, 9.Center for Clinical and Translational Research, Kagoshima University Hospital, Kagoshima, Japan)